ATE215827T1 - Immunologische aktivität der rhamnolipide - Google Patents
Immunologische aktivität der rhamnolipideInfo
- Publication number
- ATE215827T1 ATE215827T1 AT95927153T AT95927153T ATE215827T1 AT E215827 T1 ATE215827 T1 AT E215827T1 AT 95927153 T AT95927153 T AT 95927153T AT 95927153 T AT95927153 T AT 95927153T AT E215827 T1 ATE215827 T1 AT E215827T1
- Authority
- AT
- Austria
- Prior art keywords
- rhamnolipids
- immunological activity
- mono
- saturated
- polyunsaturated hydrocarbyl
- Prior art date
Links
- 230000001900 immune effect Effects 0.000 title 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Birds (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- AIDS & HIV (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/277,975 US5466675A (en) | 1992-02-04 | 1994-07-20 | Immunological activity of rhamnolipids |
PCT/US1995/008787 WO1996002233A1 (en) | 1994-07-20 | 1995-07-20 | Immunological activity of rhamnolipids |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE215827T1 true ATE215827T1 (de) | 2002-04-15 |
Family
ID=23063162
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95927153T ATE215827T1 (de) | 1994-07-20 | 1995-07-20 | Immunologische aktivität der rhamnolipide |
Country Status (8)
Country | Link |
---|---|
US (2) | US5466675A (de) |
EP (1) | EP0771191B1 (de) |
JP (2) | JP4316672B2 (de) |
AT (1) | ATE215827T1 (de) |
AU (1) | AU3126695A (de) |
CA (1) | CA2195419C (de) |
DE (1) | DE69526353D1 (de) |
WO (1) | WO1996002233A1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1889623A3 (de) * | 1998-02-24 | 2009-04-08 | Paradigm Biomedical Inc. | Verwendung von Rhamnolipiden für die Wundheilung, für die Behandlung von Verbrennungen, Arteriosklerose, Organtransplantationen, Depressionen und Schizophrenie sowie für Kosmetikartikel |
US7262171B1 (en) * | 1998-02-24 | 2007-08-28 | Paradigm Biomedical, Inc. | Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics |
ES2291036T3 (es) * | 1998-02-24 | 2008-02-16 | Paradigm Biomedical, Inc. | Uso de ramnolipidos como cosmeticos. |
WO2001010447A1 (en) * | 1999-08-05 | 2001-02-15 | Tamara Stipcevic | Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration |
US6921390B2 (en) * | 2001-07-23 | 2005-07-26 | Boston Scientific Scimed, Inc. | Long-term indwelling medical devices containing slow-releasing antimicrobial agents and having a surfactant surface |
US7262178B2 (en) | 2003-03-24 | 2007-08-28 | Polytechnic University | Treatment of sepsis and septic shock |
US20050164955A1 (en) * | 2003-11-06 | 2005-07-28 | Gross Richard A. | Antifungal properties of various forms of sophorolipids |
US7985722B2 (en) * | 2006-07-27 | 2011-07-26 | Aurora Advanced Beauty Labs | Rhamnolipid-based formulations |
US8592381B2 (en) * | 2008-12-18 | 2013-11-26 | Rhamnopharma Inc. | Method for treating rhinitis and sinusitis by rhamnolipids |
IT1393093B1 (it) | 2009-02-18 | 2012-04-11 | Bluegreen Biotech S R L | Miscela glicolipidica da oscillatoria planktothrix con attivita' immunomodulante ed antiinfiammatoria |
WO2012077120A2 (en) | 2010-12-09 | 2012-06-14 | Y&B Mother's Choice Ltd. | Natural formulations |
US10434058B2 (en) | 2010-12-09 | 2019-10-08 | Y&B Mother's Choice Ltd. | Natural formulations |
BR112013014236B1 (pt) | 2010-12-09 | 2021-03-30 | Y&B Mother's Choice Ltd | Composição cosmética ou de limpeza e produto de consumo |
EP2723348B1 (de) * | 2011-06-21 | 2019-08-14 | Anton Leighton | Verfahren zur behandlung von adipositas |
US9861702B2 (en) | 2012-10-22 | 2018-01-09 | Wisconsin Alumni Research Foundation | Lipid-conjugated rhamnose for immune system recruitment and oncotherapy |
DE102012221519A1 (de) * | 2012-11-26 | 2014-05-28 | Evonik Industries Ag | Verfahren zur Isolierung von Rhamnolipiden |
IL229836A0 (en) | 2013-12-08 | 2014-03-31 | Y & B Mother S Choice Ltd | Formulations to reduce or suppress irritation to eye tissue |
DK3292210T3 (da) * | 2015-05-05 | 2020-05-25 | Stepan Co | Semikontinuerlig fremgangsmåde til fremstilling af rhamnolipider med højt udbytte og høj titer |
EP3338762A1 (de) | 2016-12-22 | 2018-06-27 | L'oreal | Verwendung von rhamnolipid zur behandlung von hautrötung |
ES2898721T3 (es) | 2016-12-22 | 2022-03-08 | Oreal | Uso de ramnolípidos para el tratamiento cosmético de la piel reactiva |
BR112019012193B1 (pt) | 2017-04-28 | 2021-12-28 | L'oreal | Composição de desodorante, métodos para desodorização de material queratinizado e para o tratamento de odor corporal e uso da composição de desodorante |
KR102112570B1 (ko) * | 2019-01-28 | 2020-05-19 | 한국해양과학기술원 | 신규 람노리피드 화합물 및 이의 용도 |
WO2024011093A1 (en) * | 2022-07-08 | 2024-01-11 | Woolsey Pharmaceuticals, Inc. | Treating amyotrophic lateral sclerosis having onset 24 months prior to treatment |
WO2024011094A1 (en) * | 2022-07-08 | 2024-01-11 | Woolsey Pharmaceuticals, Inc. | Regimen for treating amyotrophic lateral sclerosis having onset 24 months prior to treatment |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0135099A3 (de) * | 1983-08-09 | 1987-05-13 | Petrotec Systems AG | Verfahren zur Herstellung von Tensiden |
DE3405664A1 (de) * | 1984-02-17 | 1985-09-05 | Wintershall Ag, 3100 Celle | Verfahren zur biotechnischen herstellung von rhamnolipiden und rhamnolipide mit nur einem ss-hydroxidecancarbonsaeurerest im molekuel |
JPS63182029A (ja) * | 1987-01-22 | 1988-07-27 | Agency Of Ind Science & Technol | リポソ−ム |
US4933281A (en) * | 1987-03-17 | 1990-06-12 | The University Of Iowa Research Foundation | Method for producing rhamnose |
JPS63253025A (ja) * | 1987-04-09 | 1988-10-20 | Yamanouchi Pharmaceut Co Ltd | ホスホリパ−ゼa↓2阻害剤 |
EP0288965A2 (de) * | 1987-04-29 | 1988-11-02 | Hoechst Aktiengesellschaft | Peptide mit Phospholipase A2- hemmender Wirkung |
JPH0273093A (ja) * | 1988-09-09 | 1990-03-13 | Haruo Ogura | 3−デオキシ−d−グリセロ−d−ガラクト−2−ノヌロピラノソン酸誘導体 |
IT1235162B (it) * | 1988-12-02 | 1992-06-22 | Fidia Farmaceutici | Derivati di lisosfingolipidi |
FR2645741B1 (fr) * | 1989-03-20 | 1995-06-23 | Dior Christian Parfums | Procede pour fixer un produit sur la membrane d'un keratinocyte au moyen d'une liaison ligand-recepteur, procede de preparation d'un tel produit, produit obtenu, composition cosmetique ou pharmaceutique le contenant et son procede de preparation |
BE1005704A4 (nl) * | 1992-02-04 | 1993-12-21 | Piljac Goran & Piljac Visnja | Farmaceutisch preparaat op basis van rhamnolipide. |
BE1005825A4 (nl) * | 1992-05-22 | 1994-02-08 | Piljac Goran | Oppervlakteactieve samenstelling op basis van rhamnolopide. |
-
1994
- 1994-07-20 US US08/277,975 patent/US5466675A/en not_active Expired - Lifetime
-
1995
- 1995-07-20 DE DE69526353T patent/DE69526353D1/de not_active Expired - Lifetime
- 1995-07-20 CA CA002195419A patent/CA2195419C/en not_active Expired - Fee Related
- 1995-07-20 JP JP50514196A patent/JP4316672B2/ja not_active Expired - Fee Related
- 1995-07-20 AT AT95927153T patent/ATE215827T1/de not_active IP Right Cessation
- 1995-07-20 EP EP95927153A patent/EP0771191B1/de not_active Expired - Lifetime
- 1995-07-20 WO PCT/US1995/008787 patent/WO1996002233A1/en active IP Right Grant
- 1995-07-20 AU AU31266/95A patent/AU3126695A/en not_active Abandoned
- 1995-08-28 US US08/520,076 patent/US5514661A/en not_active Expired - Lifetime
-
2007
- 2007-08-30 JP JP2007223905A patent/JP2007308514A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2195419C (en) | 2008-01-22 |
JPH10502925A (ja) | 1998-03-17 |
DE69526353D1 (de) | 2002-05-16 |
US5514661A (en) | 1996-05-07 |
CA2195419A1 (en) | 1996-02-01 |
EP0771191A4 (de) | 1998-10-07 |
EP0771191B1 (de) | 2002-04-10 |
JP4316672B2 (ja) | 2009-08-19 |
JP2007308514A (ja) | 2007-11-29 |
US5466675A (en) | 1995-11-14 |
EP0771191A1 (de) | 1997-05-07 |
AU3126695A (en) | 1996-02-16 |
WO1996002233A1 (en) | 1996-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE215827T1 (de) | Immunologische aktivität der rhamnolipide | |
FR2430410A1 (fr) | Phenethanolamines et compositions pharmaceutiques en contenant | |
ATE229524T1 (de) | Distamycin a analoga als antitumor- oder antivirale wirkstoffe | |
ATE1814T1 (de) | 9-hydroxyalkylpurine, verfahren zu ihrer herstellung und 9-hydroxyalkylpurine als aktive mittel enthaltende therapeutische zusammensetzung. | |
ATE72448T1 (de) | 2-alkynyladenosine als aktive bestandteile enthaltende antihypertensive mittel. | |
NO843836L (no) | Terapeutisk aktive sulfamatderivater | |
NO810478L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive substituerte imidazolderivater | |
GB2075341B (en) | Pharmaceutical compositions | |
GB2210556B (en) | The use of 15-keto-16-halo-prostaglandins in cathartic compositions | |
MD1688G2 (ro) | Benzotiofen, benzofuran şi indoltiazepinone, oxazepinone şi diazepinone, compoziţie farmaceutică, metodă de inhibare a aderării leucocitelor la celulele endoteliale pentru tratamentul proceselor inflamatorii şi metodă de tratament al mamiferelor infectate cu HIV infecţie . | |
FR2418214A1 (fr) | Compose de formule 1-(2',6',6'-trimethylcyclohexyl)-hexane-3-ol utilise notamment comme fixateur pour compositions de parfums | |
SE9601677D0 (sv) | New use | |
FR2426679A1 (de) | ||
ATE41772T1 (de) | Polymethoxybenzyl-piperazin-derivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen. | |
DE69205839T2 (de) | Dermatologische und kosmetische Zusammensetzung. | |
FR2445329A1 (fr) | Derives du 11-bromo-14-oxo-15-hydroxy-imino-e-homo-eburnane, leur preparation et leur utilisation comme medicament | |
ATE202084T1 (de) | Schwefelenthaltende di-ter-butylphenol- verbindungen brauchbar als entzündungshemmende mittel | |
FR2420344A1 (fr) | Nouveaux oxime-ethers, leur preparation et leur application therapeutique. | |
FR2392966A1 (fr) | Nouveaux acides uree-bis(naphtalene-sulfoniques et naphtalene-carboxyliques), leurs sels pharmaceutiquement acceptables, et leur utilisation therapeutique | |
EP0253378A3 (de) | 13Beta-Alkyl-derivate von S541-Antibiotika zur Bekämpfung von Parasiten an Nutztieren und Pflanzen | |
DE69615657T2 (de) | Antifungal fusacandine | |
FR2374319A1 (fr) | Furanne- et thiophenecarbaldehydes substitues et furylalkylcetones substituees et thienylalkylcetones substituees, utiles notamment comme agents anti-rhinovirus, et leur procede de preparation | |
FR2414333A2 (fr) | Composition pharmaceutique contenant comme ingredient actif la d-2-bromo 6-methyl-8b-(morpholinocarbonyoxymethyl)-ergoline, utile notamment pour le traitement de l'asthme | |
FR2428026A1 (fr) | Derives de monoamides de l'acide terephtalique, leur procede de preparation et leur application en therapeutique | |
ES8500620A1 (es) | Procedimiento para la preparacion de derivados e-homo-eburnanos racemicos u opticamente activos y de sus sales de adicion acidas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |